Efficacy [qlco]
Safety [hcpp]
17 alpha-hydroxyprogesterone caproate [horm, phsu, strd]
Hormone [horm]
Replacement therapy [topp]
Present [qnco]
Study [mnob]
Evaluate [ftcn]
Efficacy [qlco]
Induction [ftcn]
Uterine Bleeding [patf]
Safety [hcpp]
absence [qnco]
Endometrial Hyperplasia [dsyn]
17 alpha-hydroxyprogesterone caproate [horm, phsu, strd]
Therapeutic regimen [topp]
Hormonal [qlco]
Replacement [topp]
Menopause [phsf]
postmenopausal [tmco]
Patients [podg]
Received [qlco]
Hormone replacement therapy [topp]
weeks [tmco]
Treatment Regimen [topp]
Standard [qlco]
Estrogen Replacement Therapy [topp]
prescribed [hlca]
Doses [qnco]
Prevention [topp]
Climacteric [orgf]
symptoms [ftcn]
mg% [qnco]
17 alpha-hydroxyprogesterone caproate [horm, phsu, strd]
days [tmco]
Women [popg]
Withdrawal [acty]
Bleeding [patf]
7 days [tmco]
Administration [ocac]
17 alpha-hydroxyprogesterone caproate [horm, phsu, strd]
Eight [qnco]
Patients [podg]
COMPLETED [qlco]
Trial [resa]
Cases [ftcn]
Patients [podg]
experience [menp]
Expected [idcn]
Pattern [spco]
i e [diap, inpr]
Withdrawal bleeding [dsyn]
Form [qlco]
Bleeding [patf]
Breakthrough Bleeding [patf]
forms [qlco]
Abnormal bleeding [patf]
Affected [ftcn]
Women [popg]
endometrial sampling [diap]
endometrium thickness [qnco]
Heterogeneous [qlco]
Cases [ftcn]
Carcinoma [neop]
biopsies [diap]
Performed [ftcn]
End [spco]
treatment [ftcn]
Serious [qlco]
Adverse Effect [fndg]
Record [inpr]
Study [mnob]
Efficacy [qlco]
Safety [hcpp]
17 alpha-hydroxyprogesterone caproate [horm, phsu, strd]
Hormone replacement therapy [topp]
